onvansertib with cytarabine or decitabine for r/r aml
Published 4 years ago • 219 plays • Length 2:06
Download video MP4
Download video MP3
Similar videos
-
3:35
onvansertib with cytarabine or decitabine for r/r aml
-
1:32
onvansertib plus decitabine for patients with r/r aml
-
2:41
onvansertib and decitabine in relapsed/refractory aml
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
3:53
investigating the combination of pivekimab sunirine, azacitidine & venetoclax in r/r aml
-
2:16
rationale for 10-day decitabine with venetoclax for high-risk aml
-
1:36
the synergetic mechanism of pivekimab sunirine and venetoclax and its potential for treating aml
-
2:18
the all-oral regimen of decitabine/cedazuridine, venetoclax, & gilteritinib for older pts with aml
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
3:33
dna methylation and decitabine
-
1:40
pivekimab sunirine in combination with venetoclax and azacitidine for cd123-positive aml
-
2:23
oral combination of astx727 (decitabine/cedazuridine) plus ven for older/unfit patients with aml
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:23
decitabine, venetoclax, and idh inhibitor in idh-mutated aml
-
1:27
quizartinib, venetoclax, and decitabine in patients with flt3-itd aml: a phase i/ii trial
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:07
an insight into the cadenza study: pivekimab sunirine in patients with r/r bpdcn
-
1:51
thrombotic and bleeding complications in al amyloidosis
Clip.africa.com - Privacy-policy